Annual Cash & Cash Equivalents
$488.10 M
+$84.30 M+20.88%
December 31, 2024
Summary
- As of February 25, 2025, BIO annual cash & cash equivalents is $488.10 million, with the most recent change of +$84.30 million (+20.88%) on December 31, 2024.
- During the last 3 years, BIO annual cash & cash equivalents has risen by +$17.32 million (+3.68%).
- BIO annual cash & cash equivalents is now -46.16% below its all-time high of $906.55 million, reached on December 31, 2010.
Performance
BIO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$488.10 M
+$77.72 M+18.94%
December 31, 2024
Summary
- As of February 25, 2025, BIO quarterly cash and cash equivalents is $488.10 million, with the most recent change of +$77.72 million (+18.94%) on December 31, 2024.
- Over the past year, BIO quarterly cash and cash equivalents has increased by +$54.82 million (+12.65%).
- BIO quarterly cash and cash equivalents is now -46.16% below its all-time high of $906.55 million, reached on December 31, 2010.
Performance
BIO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BIO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.9% | +12.7% |
| 3 y3 years | +3.7% | +12.4% |
| 5 y5 years | -26.1% | +12.4% |
BIO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.9% | -39.2% | +25.1% |
| 5 y | 5-year | -26.3% | +20.9% | -43.2% | +25.1% |
| alltime | all time | -46.2% | >+9999.0% | -46.2% | >+9999.0% |
Bio-Rad Laboratories Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $488.10 M(+20.9%) | $488.10 M(+18.9%) |
| Sep 2024 | - | $410.38 M(+0.9%) |
| Jun 2024 | - | $406.91 M(-6.1%) |
| Mar 2024 | - | $433.28 M(+7.3%) |
| Dec 2023 | $403.80 M(-7.0%) | $403.80 M(-11.8%) |
| Sep 2023 | - | $457.85 M(+17.4%) |
| Jun 2023 | - | $390.00 M(-16.0%) |
| Mar 2023 | - | $464.14 M(+6.9%) |
| Dec 2022 | $434.21 M(-7.8%) | $434.21 M(-16.2%) |
| Sep 2022 | - | $517.94 M(-13.2%) |
| Jun 2022 | - | $596.58 M(-25.6%) |
| Mar 2022 | - | $802.32 M(+70.4%) |
| Dec 2021 | $470.78 M(-28.9%) | $470.78 M(-45.3%) |
| Sep 2021 | - | $859.90 M(+17.3%) |
| Jun 2021 | - | $732.84 M(+8.8%) |
| Mar 2021 | - | $673.47 M(+1.7%) |
| Dec 2020 | $662.21 M(+0.2%) | $662.21 M(-21.2%) |
| Sep 2020 | - | $840.33 M(+38.3%) |
| Jun 2020 | - | $607.58 M(+0.7%) |
| Mar 2020 | - | $603.55 M(-8.6%) |
| Dec 2019 | $660.67 M(+53.1%) | $660.67 M(+17.8%) |
| Sep 2019 | - | $561.07 M(-3.4%) |
| Jun 2019 | - | $580.68 M(+27.4%) |
| Mar 2019 | - | $455.89 M(+5.6%) |
| Dec 2018 | $431.53 M(+12.4%) | $431.53 M(-0.7%) |
| Sep 2018 | - | $434.52 M(+7.8%) |
| Jun 2018 | - | $403.01 M(-1.0%) |
| Mar 2018 | - | $407.27 M(+6.1%) |
| Dec 2017 | $383.82 M(-15.9%) | $383.82 M(+16.7%) |
| Sep 2017 | - | $328.89 M(+2.3%) |
| Jun 2017 | - | $321.58 M(+10.3%) |
| Mar 2017 | - | $291.66 M(-36.1%) |
| Dec 2016 | $456.26 M(-0.3%) | $456.26 M(+9.2%) |
| Sep 2016 | - | $417.94 M(-0.2%) |
| Jun 2016 | - | $418.65 M(+3.7%) |
| Mar 2016 | - | $403.62 M(-11.8%) |
| Dec 2015 | $457.55 M(+10.7%) | $457.55 M(-9.8%) |
| Sep 2015 | - | $507.33 M(+12.7%) |
| Jun 2015 | - | $450.13 M(+5.7%) |
| Mar 2015 | - | $425.73 M(+3.0%) |
| Dec 2014 | $413.25 M(+24.6%) | $413.25 M(-2.7%) |
| Sep 2014 | - | $424.59 M(+10.4%) |
| Jun 2014 | - | $384.67 M(+5.5%) |
| Mar 2014 | - | $364.51 M(+9.9%) |
| Dec 2013 | $331.55 M(-28.5%) | $331.55 M(+13.6%) |
| Sep 2013 | - | $291.79 M(-20.5%) |
| Jun 2013 | - | $367.00 M(-0.4%) |
| Mar 2013 | - | $368.63 M(-20.4%) |
| Dec 2012 | $463.39 M(-19.3%) | $463.39 M(+8.7%) |
| Sep 2012 | - | $426.46 M(-6.6%) |
| Jun 2012 | - | $456.49 M(-14.5%) |
| Mar 2012 | - | $533.81 M(-7.0%) |
| Dec 2011 | $574.23 M(-36.7%) | $574.23 M(-14.4%) |
| Sep 2011 | - | $671.03 M(+0.1%) |
| Jun 2011 | - | $670.30 M(+6.8%) |
| Mar 2011 | - | $627.91 M(-30.7%) |
| Dec 2010 | $906.55 M(+39.5%) | $906.55 M(+43.8%) |
| Sep 2010 | - | $630.64 M(+2.7%) |
| Jun 2010 | - | $614.22 M(+2.7%) |
| Mar 2010 | - | $598.13 M(-8.0%) |
| Dec 2009 | $649.94 M(+217.8%) | $649.94 M(+17.3%) |
| Sep 2009 | - | $554.18 M(+3.9%) |
| Jun 2009 | - | $533.47 M(+176.6%) |
| Mar 2009 | - | $192.87 M(-5.7%) |
| Dec 2008 | $204.52 M(+26.4%) | $204.52 M(+5.6%) |
| Sep 2008 | - | $193.63 M(+5.4%) |
| Jun 2008 | - | $183.64 M(+41.8%) |
| Mar 2008 | - | $129.48 M(-20.0%) |
| Dec 2007 | $161.76 M(-27.7%) | $161.76 M(-65.8%) |
| Sep 2007 | - | $472.79 M(+103.4%) |
| Jun 2007 | - | $232.40 M(+0.9%) |
| Mar 2007 | - | $230.31 M(+3.0%) |
| Dec 2006 | $223.61 M | $223.61 M(-6.2%) |
| Sep 2006 | - | $238.42 M(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $245.65 M(-7.5%) |
| Mar 2006 | - | $265.59 M(-10.5%) |
| Dec 2005 | $296.72 M(+51.6%) | $296.72 M(+21.6%) |
| Sep 2005 | - | $243.98 M(-3.2%) |
| Jun 2005 | - | $252.13 M(-20.7%) |
| Mar 2005 | - | $317.90 M(+62.4%) |
| Dec 2004 | $195.73 M(+199.3%) | $195.73 M(+56.4%) |
| Sep 2004 | - | $125.15 M(-19.4%) |
| Jun 2004 | - | $155.33 M(+9.7%) |
| Mar 2004 | - | $141.55 M(+116.5%) |
| Dec 2003 | $65.39 M(+135.8%) | $65.39 M(-53.5%) |
| Sep 2003 | - | $140.75 M(+388.2%) |
| Jun 2003 | - | $28.83 M(+14.3%) |
| Mar 2003 | - | $25.22 M(-9.1%) |
| Dec 2002 | $27.73 M(-41.2%) | $27.73 M(-29.3%) |
| Sep 2002 | - | $39.25 M(+53.0%) |
| Jun 2002 | - | $25.66 M(-42.9%) |
| Mar 2002 | - | $44.95 M(-4.6%) |
| Dec 2001 | $47.13 M(+237.7%) | $47.13 M(+45.8%) |
| Sep 2001 | - | $32.33 M(+24.0%) |
| Jun 2001 | - | $26.07 M(+160.8%) |
| Mar 2001 | - | $9.99 M(-28.4%) |
| Dec 2000 | $13.95 M(-18.4%) | $13.95 M(+62.5%) |
| Sep 2000 | - | $8.59 M(-34.3%) |
| Jun 2000 | - | $13.07 M(-14.7%) |
| Mar 2000 | - | $15.32 M(-10.4%) |
| Dec 1999 | $17.10 M(+69.3%) | $17.10 M(+44.9%) |
| Sep 1999 | - | $11.80 M(+1.7%) |
| Jun 1999 | - | $11.60 M(+45.0%) |
| Mar 1999 | - | $8.00 M(-20.8%) |
| Dec 1998 | $10.10 M(-6.5%) | $10.10 M(+21.7%) |
| Sep 1998 | - | $8.30 M(-38.5%) |
| Jun 1998 | - | $13.50 M(+7.1%) |
| Mar 1998 | - | $12.60 M(+16.7%) |
| Dec 1997 | $10.80 M(+14.9%) | $10.80 M(+129.8%) |
| Sep 1997 | - | $4.70 M(-14.5%) |
| Jun 1997 | - | $5.50 M(-48.6%) |
| Mar 1997 | - | $10.70 M(+13.8%) |
| Dec 1996 | $9.40 M(-36.5%) | $9.40 M(-62.8%) |
| Sep 1996 | - | $25.30 M(-4.2%) |
| Jun 1996 | - | $26.40 M(+46.7%) |
| Mar 1996 | - | $18.00 M(+21.6%) |
| Dec 1995 | $14.80 M(+289.5%) | $14.80 M(+94.7%) |
| Sep 1995 | - | $7.60 M(+52.0%) |
| Jun 1995 | - | $5.00 M(-15.3%) |
| Mar 1995 | - | $5.90 M(+55.3%) |
| Dec 1994 | $3.80 M(+22.6%) | $3.80 M(-2.6%) |
| Sep 1994 | - | $3.90 M(-18.8%) |
| Jun 1994 | - | $4.80 M(-15.8%) |
| Mar 1994 | - | $5.70 M(+83.9%) |
| Dec 1993 | $3.10 M(+14.8%) | $3.10 M(+19.2%) |
| Sep 1993 | - | $2.60 M(-33.3%) |
| Jun 1993 | - | $3.90 M(+2.6%) |
| Mar 1993 | - | $3.80 M(+40.7%) |
| Dec 1992 | $2.70 M(-43.8%) | $2.70 M(+12.5%) |
| Sep 1992 | - | $2.40 M(-35.1%) |
| Jun 1992 | - | $3.70 M(-27.5%) |
| Mar 1992 | - | $5.10 M(+6.3%) |
| Dec 1991 | $4.80 M(+140.0%) | $4.80 M(+71.4%) |
| Sep 1991 | - | $2.80 M(+12.0%) |
| Jun 1991 | - | $2.50 M(-24.2%) |
| Mar 1991 | - | $3.30 M(+65.0%) |
| Dec 1990 | $2.00 M(-31.0%) | $2.00 M(-42.9%) |
| Sep 1990 | - | $3.50 M(-28.6%) |
| Jun 1990 | - | $4.90 M(0.0%) |
| Mar 1990 | - | $4.90 M(+69.0%) |
| Dec 1989 | $2.90 M(-27.5%) | $2.90 M(-21.6%) |
| Sep 1989 | - | $3.70 M(+60.9%) |
| Jun 1989 | - | $2.30 M(-42.5%) |
| Dec 1988 | $4.00 M(+110.5%) | $4.00 M(+110.5%) |
| Dec 1987 | $1.90 M(-9.5%) | $1.90 M(-9.5%) |
| Dec 1986 | $2.10 M(-65.0%) | $2.10 M(-65.0%) |
| Dec 1985 | $6.00 M(+566.7%) | $6.00 M(+566.7%) |
| Dec 1984 | $900.00 K | $900.00 K |
FAQ
- What is Bio-Rad Laboratories annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual cash & cash equivalents year-on-year change?
- What is Bio-Rad Laboratories quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly cash and cash equivalents year-on-year change?
What is Bio-Rad Laboratories annual cash & cash equivalents?
The current annual cash & cash equivalents of BIO is $488.10 M
What is the all time high annual cash & cash equivalents for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual cash & cash equivalents is $906.55 M
What is Bio-Rad Laboratories annual cash & cash equivalents year-on-year change?
Over the past year, BIO annual cash & cash equivalents has changed by +$84.30 M (+20.88%)
What is Bio-Rad Laboratories quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BIO is $488.10 M
What is the all time high quarterly cash and cash equivalents for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly cash and cash equivalents is $906.55 M
What is Bio-Rad Laboratories quarterly cash and cash equivalents year-on-year change?
Over the past year, BIO quarterly cash and cash equivalents has changed by +$54.82 M (+12.65%)